SETDB1 upregulation was reported to be closely related to the progression and poor prognosis of patients with HCC and was found in all metastatic foci, demonstrating the important role of SETDB1 in HCC aggressiveness. This evidence concerns the gene SETDB1 and hepatocellular carcinoma.